NDC 17163-015 - API General Cure
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17163-015
- Package NDCs from labels
- 17163-015-16
- Manufacturer
- MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited
- Effective date
- 2022-04-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PRAZIQUANTEL - MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited | MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited | 2022-04-19 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17163-015-16 | API General Cure | 2 g in 1 PACKET | POWDER | 2 | 6 | |
| 17163-015-16 | API General Cure | 10 in 1 BOX | POWDER | 10 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | Northwind Health Company, LLC | f7e5dacd-0bc4-4ac4-e053-6394a90a457a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Proficient Rx LP | a56c2842-8ad4-4396-8eb6-cbcd1629fcb1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Redpharm Drug | 300b51d0-8fca-24ef-e063-6294a90ad2b9 | 2025-12-23 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Redpharm Drug | 32523df9-8c47-200f-e063-6294a90ac890 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Chartwell RX, LLC | 40509b3c-b725-400c-abe5-d6d5714d405d | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | 60ad086d-6f54-4134-b608-53a6ff571ff8 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | 2a5af710-dbf7-41c1-9b3a-35e69b3fa4ab | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | 9a18debb-3bb8-4b23-949b-aaa0f3b62191 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Vandazole | METRONIDAZOLE | Upsher-smith Laboratories, LLC | 27d71471-8f89-4a1e-8c55-020a58961454 | 2025-12-02 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Civica, Inc. | 902ab25b-d493-495a-884e-96b080e9f72d | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Hospira, Inc. | 49360d6f-c8b3-420e-af75-154cf7b05255 | 2025-11-19 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 4c7f024d-ba26-43cf-a36f-597e2168cd9f | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | ac7e80ce-6174-4246-a955-a92adc516571 | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole vaginal | METRONIDAZOLE | A-S Medication Solutions | 58ce793b-9b6a-4cd7-94ae-215dbf9e2ef7 | 2025-10-29 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | 353b7f5b-4bbc-4ec9-84ba-d82656ea1811 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole Vaginal Gel, 0.75% | METRONIDAZOLE | Encube Ethicals, Inc. | 63ed1e7e-d264-4e35-af83-ec37fa5b06d1 | 2025-10-09 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | 8f1de4ca-a005-4ca9-a43a-380429c80d6f | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | 4cdd7ac5-a52c-4766-afeb-1b5e567a328c | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | aea4e2a1-2089-40dc-9eee-deaab4f21397 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | b85bdc1f-1ffb-40d5-a407-e8de2891996d | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.